BBA
ROIV icon

Baader Bank Aktiengesellschaft’s Roivant Sciences ROIV Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$498K Buy
14,068
+63
+0.4% +$1.86K 0.04% 269
2026
Q1 		$388K Sell
14,005
-33,612
-71% -$863K 0.03% 312
2025
Q4 		$1.03M Buy
+47,617
New +$939K 0.07% 181
2024
Q4 		– Sell
-25,692
Closed -$294K – 480
2024
Q3 		$294K Buy
+25,692
New +$293K 0.02% 297

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Baader Bank Aktiengesellschaft's ROIV Position: Q2 2026 in Review

Baader Bank Aktiengesellschaft increased its Roivant Sciences (ROIV) stake by 0.45% in Q2 2026, buying an estimated $1.86K and bringing the position to 14,068 shares worth $498K. The position accounts for 0.04% of the portfolio, ranked #269.

Baader Bank Aktiengesellschaft first reported a position in ROIV in Q3 2024 and has held it in 4 quarters since. The position peaked at $1.03M in Q4 2025. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Baader Bank Aktiengesellschaft held 14,068 shares of Roivant Sciences worth $498K as of Q2 2026.
  • Baader Bank Aktiengesellschaft bought 63 Roivant Sciences shares in Q2 2026, an estimated $1.86K.
  • Roivant Sciences made up 0.04% of Baader Bank Aktiengesellschaft's portfolio in Q2 2026, its #269 holding.
  • Baader Bank Aktiengesellschaft first reported a position in Roivant Sciences in Q3 2024 and has held it in 4 quarters since.
  • Baader Bank Aktiengesellschaft's Roivant Sciences position peaked at $1.03M in Q4 2025.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q2 2026, filed 23 Jul 2026.